Chaperna-mediated assembly of ferritin-based middle East respiratory syndrome-coronavirus nanoparticles

Frontiers in Immunology

Volumn 9, Issue MAY, 2018, Pages

  Kim, Young Seok ^a   Son, Ahyun ^a   Kim, Jihoon ^a   Kwon, Soon Bin ^a   Kim, Myung Hee ^b   Kim, Paul ^a   Kim, Jieun ^a   Byun, Young Ho ^a   Sung, Jemin ^a   Lee, Jinhee ^a   Yu, Ji Eun ^a   Park, Chan ^a   Kim, Yeon Sook ^c   Cho, Nam Hyuk ^d   Chang, Jun ^b   Seong, Baik L ^a  

^a Yonsei University   (South Korea)

^b Ewha Womans University   (South Korea)

^c Chungnam National University   (South Korea)

^d Seoul National University College of Medicine   (South Korea)

Author keywords

Chaperone; Ferritin; Lysyl tRNA synthetase; Middle East respiratory syndrome coronavirus; nanoparticle; Receptor binding domain; RNA interacting domain of human LysRS; Virus like particle

Indexed keywords

BACTERIOFERRITIN; CHAPERONE; FERRITIN; NANOPARTICLE; RECOMBINANT VACCINE; RIBONUCLEASE A; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; CRYOELECTRON MICROSCOPY; ENZYME LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; EXPRESSION VECTOR; FEMALE; FLOW CYTOMETRY; GEL MOBILITY SHIFT ASSAY; GENE MUTATION; GENE SYNTHESIS; IMMUNIZATION; MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS; MOUSE; NONHUMAN; PHOTON CORRELATION SPECTROSCOPY; POLYACRYLAMIDE GEL ELECTROPHORESIS; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; PROTEIN PURIFICATION; PROTEIN RNA BINDING; SIZE EXCLUSION CHROMATOGRAPHY; TRANSMISSION ELECTRON MICROSCOPY; VIRUS INFECTION; WESTERN BLOTTING;

EID: 85047091892     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2018.01093     Document Type: Article

References (68)

1. Jeong H, Seong BL. Exploiting virus-like particles as innovative vaccines against emerging viral infections. J Microbiol (2017) 55(3):220-30. doi:10.1007/s12275-017-7058-3
2. Wong S-S, Webby RJ. Traditional and new influenza vaccines. Clin Microbiol Rev (2013) 26(3):476-92. doi:10.1128/CMR.00097-12
3. Ulmer JB, Valley U, Rappuoli R. Vaccine manufacturing: challenges and solutions. Nat Biotechnol (2006) 24(11):1377-83. doi:10.1038/nbt1261
4. Gunther S, Feldmann H, Geisbert TW, Hensley LE, Rollin PE, Nichol ST, et al. Management of accidental exposure to Ebola virus in the biosafety level 4 laboratory, Hamburg, Germany. J Infect Dis (2011) 204(Suppl 3):S785-90. doi:10.1093/infdis/jir298
5. Gregory AE, Titball R, Williamson D. Vaccine delivery using nanoparticles. Front Cell Infect Microbiol (2013) 3:13. doi:10.3389/fcimb.2013.00013
6. Bachmann MF, Jennings GT. Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns. Nat Rev Immunol (2010) 10(11):787-96. doi:10.1038/nri2868
7. Kushnir N, Streatfield SJ, Yusibov V. Virus-like particles as a highly efficient vaccine platform: diversity of targets and production systems and advances in clinical development. Vaccine (2012) 31(1):58-83. doi:10.1016/j.vaccine.2012.10.083
8. Bachmann MF, Rohrer UH, Kundig TM, Burki K, Hengartner H, Zinkernagel RM. The influence of antigen organization on B cell responsiveness. Science (1993) 262(5138):1448-51. doi:10.1126/science.8248784
9. Guu TS, Liu Z, Ye Q, Mata DA, Li K, Yin C, et al. Structure of the hepatitis E virus-like particle suggests mechanisms for virus assembly and receptor binding. Proc Natl Acad Sci U S A (2009) 106(31):12992-7. doi:10.1073/pnas.0904848106
10. Hagensee ME, Yaegashi N, Galloway DA. Self-assembly of human papillomavirus type 1 capsids by expression of the L1 protein alone or by coexpression of the L1 and L2 capsid proteins. J Virol (1993) 67(1):315-22
11. Roden R, Wu T-C. How will HPV vaccines affect cervical cancer? Nat Rev Cancer (2006) 6(10):753-63. doi:10.1038/nrc1973
12. Kang S-M, Kim M-C, Compans RW. Virus-like particles as universal influenza vaccines. Expert Rev Vaccines (2012) 11(8):995-1007. doi:10.1586/erv.12.70
13. Webb B, Sali A. Comparative protein structure modeling using MODELLER. Curr Protoc Bioinformatics (2014) 47:561-32. doi:10.1002/0471250953.bi0506s47
14. Raman S, Machaidze G, Lustig A, Aebi U, Burkhard P. Structure-based design of peptides that self-assemble into regular polyhedral nanoparticles. Nanomedicine (2006) 2(2):95-102. doi:10.1016/j.nano.2006.04.007
15. Martí-Renom MA, Stuart AC, Fiser A, Sánchez R, Melo F, Šali A. Comparative protein structure modeling of genes and genomes. Annu Rev Biophys Biomol Struct (2000) 29(1):291-325. doi:10.1146/annurev.biophys.29.1.291
16. Zeltins A. Construction and characterization of virus-like particles: a review. Mol Biotechnol (2013) 53(1):92-107. doi:10.1007/s12033-012-9598-4
17. Lopez-Sagaseta J, Malito E, Rappuoli R, Bottomley MJ. Self-assembling protein nanoparticles in the design of vaccines. Comput Struct Biotechnol J (2016) 14:58-68. doi:10.1016/j.csbj.2015.11.001
18. Fang N, Frazer IH, Fernando GJ. Differences in the post-translational modifications of human papillomavirus type 6b major capsid protein expressed from a baculovirus system compared with a vaccinia virus system. Biotechnol Appl Biochem (2000) 32(1):27-33. doi:10.1042/BA20000001
19. Zaki AM, Van Boheemen S, Bestebroer TM, Osterhaus AD, Fouchier RA. Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. New Engl J Med (2012) 367(19):1814-20. doi:10.1056/NEJMoa1211721
20. Engler O, Klingström J, Aliyev E, Niederhauser C, Fontana S, Strasser M, et al. Middle East respiratory syndrome coronavirus (MERS-CoV) serology in major livestock species in an affected region in Jordan, June to September 2013. Euro Surveill (2013) 18(50):20662. doi:10.2807/1560-7917.ES2013.18.50.20662
21. Memish ZA, Cotten M, Meyer B, Watson SJ, AlsahafiAJ, Al Rabeeah AA, et al. Human infection with MERS coronavirus after exposure to infected camels, Saudi Arabia, 2013. Emerg Infect Dis (2014) 20(6):1012. doi:10.3201/eid2006.140402
22. Breban R, Riou J, Fontanet A. Interhuman transmissibility of Middle East respiratory syndrome coronavirus: estimation of pandemic risk. Lancet (2013) 382(9893):694-9. doi:10.1016/S0140-6736(13)61492-0
23. Choi JY. An outbreak of middle east respiratory syndrome coronavirus infection in South Korea, 2015. Yonsei Med J (2015) 56(5):1174. doi:10.3349/ymj.2015.56.5.1174
24. Ki M. 2015 MERS outbreak in Korea: hospital-to-hospital transmission. Epidemiol Health (2015) 37:e2015033. doi:10.4178/epih/e2015033
25. Yariv J, Kalb A, Sperling R, Bauminger E, Cohen S, Ofer S. The composition and the structure of bacterioferritin of Escherichia coli. Biochem J (1981) 197(1):171-5. doi:10.1042/bj1970171
26. Zhang Y, Orner BP. Self-assembly in the ferritin nano-cage protein superfamily. Int J Mol Sci (2011) 12(8):5406-21. doi:10.3390/ijms12085406
27. He L, de Val N, Morris CD, Vora N, Thinnes TC, Kong L, et al. Presenting native-like trimeric HIV-1 antigens with self-assembling nanoparticles. Nat Commun (2016) 7:12041. doi:10.1038/ncomms12041
28. Yassine HM, Boyington JC, McTamney PM, Wei C-J, Kanekiyo M, Kong W-P, et al. Hemagglutinin-stem nanoparticles generate heterosubtypic influenza protection. Nat Med (2015) 21(9):1065-70. doi:10.1038/nm.3927
29. Todd TJ, Zhen Z, Xie J. Ferritin nanocages: great potential as clinically translatable drug delivery vehicles? Nanomedicine (2013) 8(10):1555-7. doi:10.2217/nnm.13.141
30. Clark EDB. Refolding of recombinant proteins. Curr Opin Biotechnol (1998) 9(2):157-63. doi:10.1016/S0958-1669(98)80109-2
31. Lilie H, Schwarz E, Rudolph R. Advances in refolding of proteins produced in E. coli. Curr Opin Biotechnol (1998) 9(5):497-501. doi:10.1016/S0958-1669(98)80035-9
32. Hendrick J, Hartl F. The role of molecular chaperones in protein folding. FASEB J (1995) 9(15):1559-69. doi:10.1096/fasebj.9.15.8529835
33. Hartl FU, Hayer-Hartl M. Molecular chaperones in the cytosol: from nascent chain to folded protein. Science (2002) 295(5561):1852-8. doi:10.1126/science.1068408
34. Bukau B, Horwich AL. The Hsp70 and Hsp60 chaperone machines. Cell (1998) 92(3):351-66. doi:10.1016/S0092-8674(00)80928-9
35. Choi SI, Ryu K, Seong BL. RNA-mediated chaperone type for de novo protein folding. RNA Biol (2009) 6(1):21-4. doi:10.4161/rna.6.1.7441
36. Son A, Choi SI, Han G, Seong BL. M1 RNA is important for the in-cell solubility of its cognate C5 protein: implications for RNA-mediated protein folding. RNA Biol (2015) 12(11):1198-208. doi:10.1080/15476286.2015.1096487
37. Horowitz S, Bardwell JC. RNAs as chaperones. RNA Biol (2016) 13(12):1228-31. doi:10.1080/15476286.2016.1247147
38. Kim JM, Choi HS, Seong BL. The folding competence of HIV-1 Tat mediated by interaction with TAR RNA. RNA Biol (2017) 14(7):926-37. doi:10.1080/15476286.2017.1311455
39. Choi SI, Han KS, Kim CW, Ryu K-S, Kim BH, Kim K-H, et al. Protein solubility and folding enhancement by interaction with RNA. PLoS One (2008) 3(7):e2677. doi:10.1371/journal.pone.0002677
40. Fiser A, Do RK, Sali A. Modeling of loops in protein structures. Protein Sci (2000) 9(9):1753-73. doi:10.1110/ps.9.9.1753
41. Comeau SR, Gatchell DW, Vajda S, Camacho CJ. ClusPro: a fully automated algorithm for protein-protein docking. Nucleic Acids Res (2004) 32(Web Server issue):W96-9. doi:10.1093/nar/gkh354
42. Kozakov D, Hall DR, Xia B, Porter KA, Padhorny D, Yueh C, et al. The ClusPro web server for protein-protein docking. Nat Protoc (2017) 12(2):255-78. doi:10.1038/nprot.2016.169
43. Lee J-Y, Chang J. Universal vaccine against respiratory syncytial virus A and B subtypes. PLoS One (2017) 12(4):e0175384. doi:10.1371/journal.pone.0175384
44. Tang J, Zhang N, Tao X, Zhao G, Guo Y, Tseng C-TK, et al. Optimization of antigen dose for a receptor-binding domain-based subunit vaccine against MERS coronavirus. Hum Vaccin Immunother (2015) 11(5):1244-50. doi:10.1080/21645515.2015.1021527
45. Du L, Kou Z, Ma C, Tao X, Wang L, Zhao G, et al. A truncated receptor-binding domain of MERS-CoV spike protein potently inhibits MERS-CoV infection and induces strong neutralizing antibody responses: implication for developing therapeutics and vaccines. PLoS One (2013) 8(12):e81587. doi:10.1371/journal.pone.0081587
46. Raj VS, Mou H, Smits SL, Dekkers DH, Müller MA, Dijkman R, et al. Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC. Nature (2013) 495(7440):251. doi:10.1038/nature12005
47. Xia S, Liu Q, Wang Q, Sun Z, Su S, Du L, et al. Middle East respiratory syndrome coronavirus (MERS-CoV) entry inhibitors targeting spike protein. Virus Res (2014) 194:200-10. doi:10.1016/j.virusres.2014.10.007
48. Lu G, Hu Y, Wang Q, Qi J, Gao F, Li Y, et al. Molecular basis of binding between novel human coronavirus MERS-CoV and its receptor CD26. Nature (2013) 500(7461):227-31. doi:10.1038/nature12328
49. Wang N, Shi X, Jiang L, Zhang S, Wang D, Tong P, et al. Structure of MERS-CoV spike receptor-binding domain complexed with human receptor DPP4. Cell Res (2013) 23(8):986-93. doi:10.1038/cr.2013.92
50. Lu L, Liu Q, Zhu Y, Chan K-H, Qin L, Li Y, et al. Structure-based discovery of Middle East respiratory syndrome coronavirus fusion inhibitor. Nat Commun (2014) 5:3067. doi:10.1038/ncomms4067
51. Kilic MA, Spiro S, Moore GR. Stability of a 24-meric homopolymer: comparative studies of assembly-defective mutants of Rhodobacter capsulatus bacterioferritin and the native protein. Protein Sci (2003) 12(8):1663-74. doi:10.1110/ps.0301903
52. Sanchez R, Sali A. Evaluation of comparative protein structure modeling by MODELLER-3. Proteins (1997) (Suppl 1):50-8. doi:10.1002/(SICI)1097-0134(1997)1+<50::AID-PROT8>3.0.CO;2-S
53. Worwood M. Ferritin. Blood Rev (1990) 4(4):259-69. doi:10.1016/0268-960X(90)90006-E
54. Sun W, Jiao C, Xiao Y, Wang L, Yu C, Liu J, et al. Salt-dependent aggregation and assembly of E coli-expressed ferritin. Dose Response (2016) 14(1):1559325816632102. doi:10.1177/1559325816632102
55. Theil EC. Ferritin protein nanocages use ion channels, catalytic sites, and nucleation channels to manage iron/oxygen chemistry. Curr Opin Chem Biol (2011) 15(2):304-11. doi:10.1016/j.cbpa.2011.01.004
56. Yiadom KPAB, Hammamieh R, Ukpabi N, Tsang P, Yang DCH. A peptide from the extension of Lys-tRNA synthetase binds to transfer RNA and DNA. Peptides (2003) 24(7):987-98. doi:10.1016/S0196-9781(03)00188-8
57. Santner AA, Croy CH, Vasanwala FH, Uversky VN, Van YY, Dunker AK. Sweeping away protein aggregation with entropic bristles: intrinsically disordered protein fusions enhance soluble expression. Biochemistry (2012) 51(37):7250-62. doi:10.1021/bi300653m
58. Oldfield CJ, Dunker AK. Intrinsically disordered proteins and intrinsically disordered protein regions. Annu Rev Biochem (2014) 83:553-84. doi:10.1146/annurev-biochem-072711-164947
59. Dyson HJ, Wright PE. Intrinsically unstructured proteins and their functions. Nat Rev Mol cell biol (2005) 6(3):197-208. doi:10.1038/nrm1589
60. Zhang N, Channappanavar R, Ma C, Wang L, Tang J, Garron T, et al. Identification of an ideal adjuvant for receptor-binding domain-based subunit vaccines against Middle East respiratory syndrome coronavirus. Cell Mol Immunol (2016) 13(2):180. doi:10.1038/cmi.2015.03
61. Yang W, Guo W, Chang J, Zhang B. Protein/peptide-templated biomimetic synthesis of inorganic nanoparticles for biomedical applications. J Mater Chem B (2017) 5(3):401-17. doi:10.1039/C6TB02308H
62. Kanekiyo M, Wei CJ, Yassine HM, McTamney PM, Boyington JC, Whittle JR, et al. Self-assembling influenza nanoparticle vaccines elicit broadly neutralizing H1N1 antibodies. Nature (2013) 499(7456):102-6. doi:10.1038/nature12202
63. Yang SW, Jang YH, Kwon SB, Lee YJ, Chae W, Byun YH, et al. Harnessing an RNA-mediated chaperone for the assembly of influenza hemagglutinin in an immunologically relevant conformation. FASEB J (2018) 32(5):2658-75. doi:10.1096/fj.201700747RR
64. Georgopoulos CP, Hendrix RW, Casjens SR, Kaiser AD. Host participation in bacteriophage lambda head assembly. J Mol Biol (1973) 76(1):45-60. doi:10.1016/0022-2836(73)90080-6
65. Sternberg N. Properties of a mutant of Escherichia coli defective in bacteriophage lambda head formation (groE). I. Initial characterization. J Mol Biol (1973) 76(1):1-23. doi:10.1016/0022-2836(73)90079-X
66. Liu C, Young AL, Starling-Windhof A, Bracher A, Saschenbrecker S, Rao BV, et al. Coupled chaperone action in folding and assembly of hexadecameric Rubisco. Nature (2010) 463(7278):197-202. doi:10.1038/nature08651
67. Date MS, Dominy BN. Modeling the influence of salt on the hydrophobic effect and protein fold stability. Commun Comput Phys (2015) 13(1):90-106. doi:10.4208/cicp.290711.121011s
68. Kanekiyo M, Bu W, Joyce MG, Meng G, Whittle JR, Baxa U, et al. Rational design of an Epstein-Barr virus vaccine targeting the receptor-binding site. Cell (2015) 162(5):1090-100. doi:10.1016/j.cell.2015.07.043